Pathogenesis and immune response of Crimean-Congo hemorrhagic fever virus in a STAT-1 knockout mouse model

Journal of Virology

Volumn 84, Issue 21, 2010, Pages 11089-11100

  Bente, Dennis A ^a   Alimonti, Judie B ^a,b   Shieh, Wun Ju ^c   Camus, Gaëlle ^a,b   Ströher, Ute ^a,b   Zaki, Sherif ^c   Jones, Steven M ^a,b  

^a PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12P70; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 6; LIVER ENZYME; RIBAVIRIN; STAT1 PROTEIN; STAT2 PROTEIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; VIRAZOL; STAT1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL ACTIVATION; CONTROLLED STUDY; CRIMEAN CONGO HEMORRHAGIC FEVER; CRIMEAN CONGO HEMORRHAGIC FEVER VIRUS; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; FEVER; HELPER CELL; HISTOPATHOLOGY; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VIVO STUDY; KNOCKOUT MOUSE; LEUKOPENIA; LIVER; LYMPHOCYTE; MOUSE; NAIRO VIRUS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SPLEEN; THROMBOCYTOPENIA; VIRUS REPLICATION; ANIMAL; DEFICIENCY; DISEASE MODEL; DISEASE PREDISPOSITION; HUMAN; IMMUNOLOGY; NAIROVIRUS; PATHOGENICITY; PATHOLOGY;

ANIMALIA; CRIMEAN-CONGO HEMORRHAGIC FEVER VIRUS; IXODIDA; MUS; VERTEBRATA;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE SUSCEPTIBILITY; HEMORRHAGIC FEVER VIRUS, CRIMEAN-CONGO; HEMORRHAGIC FEVER, CRIMEAN; HUMANS; MICE; MICE, KNOCKOUT; STAT1 TRANSCRIPTION FACTOR;

EID: 77957966056     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01383-10     Document Type: Article

References (38)

1. Akinci, E., M. Yilmaz, H. Bodur, P. Onguru, F. N. Bayazit, A. Erbay, and G. Ozet. 2009. Analysis of lymphocyte subgroups in Crimean-Congo hemorrhagic fever. Int. J. Infect. Dis. 13:560-563. doi:10.1016/j.ijid.2008.08.027.
2. Akira, S. 1999. Functional roles of STAT family proteins: lessons from knockout mice. Stem Cells 17:138-146. doi:10.1002/stem.170138.
3. Andersson, I., H. Karlberg, M. Mousavi-Jazi, L. Martinez-Sobrido, F. Weber, and A. Mirazimi. 2008. Crimean-Congo hemorrhagic fever virus delays activation of the innate immune response. J. Med. Virol. 80:1397-1404. doi:10.1002/jmv.21222.
4. Andersson, I., A. Lundkvist, O. Haller, and A. Mirazimi. 2006. Type I interferon inhibits Crimean-Congo hemorrhagic fever virus in human target cells. J. Med. Virol. 78:216-222. doi:10.1002/jmv.20530.
5. Bereczky, S., G. Lindegren, H. Karlberg, S. Akerstrom, J. Klingstrom, and A. Mirazimi. 2010. Crimean-Congo hemorrhagic fever virus infection is lethal for adult type I interferon receptor-knockout mice. J. Gen. Virol. 91:1473-1477. doi:10.1099/vir.0.019034-0.
6. Burt, F. J., R. Swanepoel, W. J. Shieh, J. F. Smith, P. A. Leman, P. W. Greer, L. M. Coffield, P. E. Rollin, T. G. Ksiazek, C. J. Peters, and S. R. Zaki. 1997. Immunohistochemical and in situ localization of Crimean-Congo hemorrhagic fever (CCHF) virus in human tissues and implications for CCHF pathogenesis. Arch. Pathol. Lab. Med. 121:839-846.
7. Cevik, M. A., A. Erbay, H. Bodur, S. S. Eren, E. Akinci, K. Sener, P. Onguru, and A. Kubar. 2007. Viral load as a predictor of outcome in Crimean-Congo hemorrhagic fever. Clin. Infect. Dis. 45:e96-100. doi:10.1086/521244.
8. Deyde, V. M., M. L. Khristova, P. E. Rollin, T. G. Ksiazek, and S. T. Nichol. 2006. Crimean-Congo hemorrhagic fever virus genomics and global diversity. J. Virol. 80:8834-8842. doi:10.1128/JVI.00752-06.
9. Dinarello, C. A. 1996. Biologic basis for interleukin-1 in disease. Blood 87:2095-2147.
10. Ergonul, O. 2006. Crimean-Congo haemorrhagic fever. Lancet Infect. Dis. 6:203-214. doi:10.1016/S1473-3099(06)70435-2.
11. Ergonul, O. 2008. Treatment of Crimean-Congo hemorrhagic fever. Antiviral Res. 78:125-131. doi:10.1016/j.antiviral.2007.11.002.
12. Ergonul, O. 2009. Biases and misinterpretation in the assessment of the efficacy of oral ribavirin in the treatment of Crimean-Congo hemorrhagic fever. J. Infect. doi:10.1016/j.jinf.2009.08.006.
13. Ergonul, O., S. Tuncbilek, N. Baykam, A. Celikbas, and B. Dokuzoguz. 2006. Evaluation of serum levels of interleukin (IL)-6, IL-10, and tumor necrosis factor-alpha in patients with Crimean-Congo hemorrhagic fever. J. Infect. Dis. 193:941-944. doi:10.1086/500836.
14. Fagbami, A. H., O. Tomori, A. Fabiyi, and T. T. Isoun. 1975. Experimantal Congo virus (Ib-AN 7620) infection in primates. Virologie 26:33-37.
15. Fisher-Hoch, S. P., J. A. Khan, S. Rehman, S. Mirza, M. Khurshid, and J. B. McCormick. 1995. Crimean Congo-haemorrhagic fever treated with oral ribavirin. Lancet 346:472-475.
16. Fisman, D. N. 2000. Hemophagocytic syndromes and infection. Emerg. Infect. Dis. 6:601-608.
17. Geisbert, T. W., L. E. Hensley, P. B. Jahrling, T. Larsen, J. B. Geisbert, J. Paragas, H. A. Young, T. M. Fredeking, W. E. Rote, and G. P. Vlasuk. 2003. Treatment of Ebola virus infection with a recombinant inhibitor of factor VIIa/tissue factor: a study in rhesus monkeys. Lancet 362:1953-1958. doi: 10.1016/S0140-6736(03)15012-X.
18. Gowen, B. B., and M. R. Holbrook. 2008. Animal models of highly pathogenic RNA viral infections: hemorrhagic fever viruses. Antiviral Res. 78:79-90. doi:10.1016/j.antiviral.2007.10.002.
19. Graci, J. D., and C. E. Cameron. 2006. Mechanisms of action of ribavirin against distinct viruses. Rev. Med. Virol. 16:37-48. doi:10.1002/rmv.483.
20. Joubert, J. R., J. B. King, D. J. Rossouw, and R. Cooper. 1985. A nosocomial outbreak of Crimean-Congo haemorrhagic fever at Tygerberg Hospital. Part III. Clinical pathology and pathogenesis. S. Afr. Med. J. 68:722-728.
21. Leon, L. R., A. A. White, and M. J. Kluger. 1998. Role of IL-6 and TNF in thermoregulation and survival during sepsis in mice. Am. J. Physiol. 275:R269-R277.
22. Meraz, M. A., J. M. White, K. C. Sheehan, E. A. Bach, S. J. Rodig, A. S. Dighe, D. H. Kaplan, J. K. Riley, A. C. Greenlund, D. Campbell, K. Carver-Moore, R. N. DuBois, R. Clark, M. Aguet, and R. D. Schreiber. 1996. Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway. Cell 84:431-442.
23. Morrill, J. C., G. B. Jennings, T. M. Cosgriff, P. H. Gibbs, and C. J. Peters. 1989. Prevention of Rift Valley fever in rhesus monkeys with interferonalpha. Rev. Infect. Dis. 11(Suppl. 4):S815-S825.
24. Nalca, A., and C. A. Whitehouse. 2007. Crimean-Congo hemorrhagic fever virus infection among animals, p. 155-165. In O. Ergonul and C. A. Whitehouse (ed.), Crimean-Congo hemorrhagic fever: a global perspective, 1st ed., Springer, Dordrecht, Netherlands.
25. Papa, A., S. Bino, E. Velo, A. Harxhi, M. Kota, and A. Antoniadis. 2006. Cytokine levels in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 36:272-276. doi:10.1016/j.jcv.2006.04.007.
26. Peyrefitte, C. N., M. Perret, S. Garcia, R. Rodrigues, A. Bagnaud, S. Lacote, J. M. Crance, G. Vernet, D. Garin, M. Bouloy, and G. Paranhos-Baccala. 2010. Differential activation profiles of Crimean-Congo hemorrhagic fever virus- and Dugbe virus-infected antigen-presenting cells. J. Gen. Virol. 91:189-198. doi:10.1099/vir.0.015701-0.
27. Purnak, T., N. A. Selvi, and K. Altundag. 2007. Global warming may increase the incidence and geographic range of Crimean-Congo hemorrhagic fever. Med. Hypotheses 68:924-925. doi:10.1016/j.mehy.2006.09.020. (Pubitemid 46136793)
28. Schoenborn, J. R., and C. B. Wilson. 2007. Regulation of interferon-gamma during innate and adaptive immune responses. Adv. Immunol. 96:41-101. doi:10.1016/S0065-2776(07)96002-2.
29. Shepherd, A. J., P. A. Leman, and R. Swanepoel. 1989. Viremia and antibody response of small African and laboratory animals to Crimean-Congo hemorrhagic fever virus infection. Am. J. Trop. Med. Hyg. 40:541-547.
30. Smirnova, S. E. 1979. A comparative study of the Crimean hemorrhagic fever-Congo group of viruses. Arch. Virol. 62:137-143.
31. Swanepoel, R., D. E. Gill, A. J. Shepherd, P. A. Leman, J. H. Mynhardt, and S. Harvey. 1989. The clinical pathology of Crimean-Congo hemorrhagic fever. Rev. Infect. Dis. 11(Suppl. 4):S794-S800.
32. Tam, R. C., J. Y. Lau, and Z. Hong. 2001. Mechanisms of action of ribavirin in antiviral therapies. Antivir. Chem. Chemother. 12:261-272.
33. Tignor, G. H., and C. A. Hanham. 1993. Ribavirin efficacy in an in vivo model of Crimean-Congo hemorrhagic fever virus (CCHF) infection. Antiviral Res. 22:309-325.
34. Watts, D. M., M. A. Ussery, D. Nash, and C. J. Peters. 1989. Inhibition of Crimean-Congo hemorrhagic fever viral infectivity yields in vitro by ribavirin. Am. J. Trop. Med. Hyg. 41:581-585.
35. Whitehouse, C. A. 2004. Crimean-Congo hemorrhagic fever. Antiviral Res. 64:145-160. doi:10.1016/j.antiviral.2004.08.001.
36. Wolfel, R., J. T. Paweska, N. Petersen, A. A. Grobbelaar, P. A. Leman, R. Hewson, M. C. Georges-Courbot, A. Papa, S. Gunther, and C. Drosten. 2007. Virus detection and monitoring of viral load in Crimean-Congo hemorrhagic fever virus patients. Emerg. Infect. Dis. 13:1097-1100.
37. Woodall, J. P., M. C. Williams, and D. I. Simpson. 1967. Congo virus: a hitherto undescribed virus occurring in Africa. II. Identification studies. East Afr. Med. J. 44:93-98.
38. Yilmaz, M., K. Aydin, E. Akdogan, N. Sucu, M. Sonmez, S. B. Omay, and I. Koksal. 2008. Peripheral blood natural killer cells in Crimean-Congo hemorrhagic fever. J. Clin. Virol. 42:415-417. doi:10.1016/j.jcv.2008.03.003.